Posts Tagged ‘Asset centric’
F-Star collaboration
As announced today (May 31), Confluence Tax is delighted to have assisted F-star on the acquisition of the asset-centric vehicle F-Star Gamma by Denali Therapeutics, leveraging F-star’s Modular Antibody Technology™ beyond immuno-oncology. Read the full press release here.
Read MoreTax structuring advice for F-star collaboration
CONFLUENCE Tax is delighted to have provided tax structuring advice to F-star Delta, the fourth asset-centric vehicle in the F-star family, in its recent immuno-oncology collaboration. This deal underscores the attractiveness of F-star’s asset-centric business model, which provides a flexible deal-making framework while at the same time maximises the value of F-star’s bispecific programmes and…
Read MoreAsset centric biotechnology models Tax Journal article
Read and download Colin’s latest article for the Tax Journal focusing on tax issues for asset-centric biotechnology companies.
Read More